Keywords: Prostate, Quantitative Imaging
Motivation: Accurate image-based characterization of prostate lesions in the peripheral zone is critical for patient management and biopsy decision making.
Goal(s): To evaluate the utility of MRF for characterizing prostatic lesions validated with MR-TRUS fusion biopsy.
Approach: MRF-derived T1 and T2 values were combined with standard ADC assessment to characterize prostate lesions in the peripheral zone. The accuracy was evaluated with MR-TRUS fusion biopsy as the ground truth.
Results: Lesion characterization using all three tissue properties (T1, T2, and ADC) provided the highest accuracy in differentiation of clinically significant prostate cancer from low-grade prostate cancer and benign lesions.
Impact: The results from this study demonstrate the potential role of magnetic resonance fingerprinting as a quantitative imaging tool for differentiating clinically significant prostate cancers to provide critical information and increase confidence in subsequent biopsy decision-making.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords